Most active investors · Jan 1, 2026 – Oct 24, 2026
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 24, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
micro1 >$100M Series BSkild AI $1.4B UndisclosedDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
HighLife €80M Financing roundAmyl Therapeutics €8.3M Series A extensionDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Biolevate €30M Series ATurbine $25M Series BDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Atum $13.5M FundingAugustus $180M Series BDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Soteris Undisclosed Seed funding disclosureArintra $25M Series BDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
TERASi €11M SeedFreya Industries SEK 6M Funding roundDetails
Details
Details
Details
Details
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Seed 1
Axio BioPharma $2.4M Pre-seedAutoimmunity BioSolutions $1M Seed extensionDetails
New companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Productive Machines Undisclosed Growth investmentTickets for Good £3.9M Funding roundDetails
New companies 1 · Follow-on 1
Stages: Undisclosed 2
Ingosa Undisclosed Second investmentIngosa Undisclosed Strategic investmentDetails
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Paymob $35M Pre-Series CEnhance $18.2M Equity and venture-debt roundDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Amber Electric €49M Series ENavi Medical Technologies A$6.8M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Novadip Biosciences €10.4M Convertible financingTrellis Bioscience $9M Series CDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Kheops €12M FundingBrightHeart €11M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
ImpriMed $10M Series A2 bridgeLinqAlpha $22M Series ADetails
Details
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Tempo Therapeutics $14.5M FundingAcurion $4.3M SeedDetails
Details
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Seed 1
PrismML $22.3M SeedRiven Systems $7.9M Pre-SeedDetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Polyphron $20M SeedOrbital Industries $50M Series BDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Facilo, Inc. ¥6.4B Series BFiddler AI $30M Series C“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.